DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Companies / C•••••• I•••
C•••••• I•••
Cryosa is a clinical stage company developing a treatment for moderate to severe Obstructive Sleep Apnea (OSA). We believe that mask-free, hose-free, implant-free treatment is possible. Everyone is free to sleep, free to rest and free to live brighter days.
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 1
Financing history
1 rounds
- Jun 30, 2025Form D equity offering · $6.0M (form d sold) · 20 investorsFact SEC EDGAR Form D data sets (quarterly) · “C•••••• I••• filed Form D: $5,990,056 sold of $15,000,000, Biotechnology”
Investors on record
1 edges
- S•••• B••••••••• M••••••••• L•• portfolio listing Fact solasbio.com
People
1 officers, 4 directors
- L•••• S••••••••• Executive Officer/Director sec.gov
- D••• F••••• Director Fact
- J•••• E•••• Director Fact
- D••••• G••••••• Director Fact
- D•••• B••••• Director Fact
Timeline
2
- Sep 16, 2026C•••••• I••• no longer listed on S•••• B••••••••• M••••••••• L••'s portfolio pageRemoved from portfolio page Inference Venture organization websites (about, team, portfolio, thesis, news pages)
- Aug 1, 2025C•••••• I••• filed Form D: $5,990,056 sold of $15,000,000, BiotechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
18 observations
Every observation on this company
- Description: Cryosa is a clinical stage company developing a treatment for moderate to severe Obstructive Sleep Apnea (OSA). We believe that mask-free, hose-free, implant-free treatment is possible. Everyone is free to sleep, free to rest and free to live brighter days. Sep 14, 2026 Fact Portfolio company websites (about, investors, press pages)
- Entity type: Corporation Aug 1, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Biotechnology Aug 1, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Aug 1, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Aug 1, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Aug 1, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Aug 1, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $6.0M Aug 1, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $15.0M Aug 1, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Aug 1, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2025-06-30 Aug 1, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 20 Aug 1, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Aug 1, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Aug 1, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 1265 Grey Fox Rd., Suite 5, Arden Hills, MN, 55112 Aug 1, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Listed on portfolio page: S•••• B••••••••• M••••••••• L•• Sep 14, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Website status: ok Sep 14, 2026 Fact Portfolio company websites (about, investors, press pages)
- Site title: Cryosa: Breakthrough OSA Treatment Innovations Sep 14, 2026 Fact Portfolio company websites (about, investors, press pages)